As providers try to find non-addictive alternatives to opioids to treat pain, prescriptions for off-label use of gabapentin have been climbing. Perhaps best known for treating pain associated with shingles, gabapentin does not show affinity for the same types of receptor sites in the brain
The Centers for Disease Control and Prevention (CDC) has published a new study1 that confirms an increase in drug overdose deaths in 2017 compared with the previous year. The study reveals that of the 70,237 drug overdose deaths in 2017, 47,600 (67.8 percent) involved opioids, representing
Cordant Announces Expanded Mental Health Monitoring Capabilities to Increase Medication Adherence for Chronic Conditions Cordant Health Solutions™, a leading provider of innovative tools for monitoring and managing behavioral health and chronic pain patients through its unique pharmacy and drug testing programs, now offers saliva testing
The use of cannabis as an alternative to opioid therapy is gaining serious consideration. Cannabis, also known as marijuana, is still a federal Schedule I drug, meaning it is an illegal drug considered to have a high abuse potential and no medical use. However, acceptance
DENVER, Nov. 15, 2018 – Cordant Health Solutions™ a provider of innovative tools for monitoring and managing behavioral health and chronic pain patients through its unique pharmacy and drug testing programs, announced that the United States Patent and Trademark Office has issued a patent for Cordant’s
Opioid misuse and abuse is a long-standing and growing concern for workers’ compensation payers. Appropriate monitoring of injured worker compliance with a given treatment plan is an essential missing piece of the treatment puzzle. The Official Disability Guidelines and the American College of Occupational and